# Abivax Socit Anonyme Stock Z Score

 AAVXF Stock USD 12.36  0.00  0.00%
Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out ABIVAX Socit Piotroski F Score and ABIVAX Socit Valuation analysis.
 ABIVAX

## ABIVAX Z Score Analysis

ABIVAX Socit's Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
 Z Score = Sum Of 5 Factors
More About Z Score | All Equity Analysis

### Current ABIVAX Socit Z Score

1.8
Most of ABIVAX Socit's fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ABIVAX Socit Anonyme is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
 First Factor = 1.2 * ( Working Capital / Total Assets )
 Second Factor = 1.4 * ( Retained Earnings / Total Assets )
 Thrid Factor = 3.3 * ( EBITAD / Total Assets )
 Fouth Factor = 0.6 * ( Market Value of Equity / Total Liabilities )
 Fifth Factor = 0.99 * ( Revenue / Total Assets )
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
 Competition Predict ABIVAX Socit
In accordance with the company's disclosures, ABIVAX Socit Anonyme has a Z Score of 1.8. This is 73.33% lower than that of the Healthcare sector and 46.11% lower than that of the Biotechnology industry. The z score for all United States stocks is 79.36% higher than that of the company.

## ABIVAX Z Score Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ABIVAX Socit's direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of ABIVAX Socit could also be used in its relative valuation, which is a method of valuing ABIVAX Socit by comparing valuation metrics of similar companies.
ABIVAX Socit is currently under evaluation in z score category among related companies.

## ABIVAX Fundamentals

 Return On Equity -12.86 Return On Asset -0.44 Operating Margin 4.66 % Current Valuation 165.28 M Shares Outstanding 22.3 M Shares Owned By Insiders 4.67 % Shares Owned By Institutions 57.27 % Price To Earning (7.88) X Price To Book 27.57 X Price To Sales 20.65 X Revenue 37 K Gross Profit (45.52 M) EBITDA (42.25 M) Net Income (41.36 M) Cash And Equivalents 26.57 M Cash Per Share 1.58 X Total Debt 53.45 M Debt To Equity 8.03 % Current Ratio 2.03 X Book Value Per Share 0.36 X Cash Flow From Operations (45.66 M) Earnings Per Share (2.59) X Number Of Employees 24 Beta 1.26 Market Capitalization 165.36 M Total Asset 110.36 M Z Score 1.8 Net Asset 110.36 M

## About ABIVAX Socit Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze ABIVAX Socit Anonyme's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ABIVAX Socit using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ABIVAX Socit Anonyme based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
ABIVAX Socit Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. The company was incorporated in 2013 and is headquartered in Paris, France. Abivax Sa is traded on OTC Exchange in the United States.

## Be your own money manager

Our tools can tell you how much better you can do entering a position in ABIVAX Socit without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

## Did you try this?

### Run Equity Valuation Now

#### Equity Valuation

Check real value of public entities based on technical and fundamental data
 All  Next Launch Module

## Pair Trading with ABIVAX Socit

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ABIVAX Socit position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABIVAX Socit will appreciate offsetting losses from the drop in the long position's value.

### Moving against ABIVAX Pink Sheet

 - 0.74 VZ Verizon Communications PairCorr - 0.59 WXIBF WuXi Biologics PairCorr - 0.58 NVO Novo Nordisk AS Fiscal Quarter End 31st of December 2023 PairCorr - 0.56 SGEN Seagen Inc Fiscal Quarter End 31st of December 2023 PairCorr - 0.56 DIS Walt Disney Fiscal Quarter End 31st of December 2023 PairCorr
The ability to find closely correlated positions to ABIVAX Socit could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ABIVAX Socit when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ABIVAX Socit - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ABIVAX Socit Anonyme to buy it.
The correlation of ABIVAX Socit is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ABIVAX Socit moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ABIVAX Socit Anonyme moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ABIVAX Socit can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Check out ABIVAX Socit Piotroski F Score and ABIVAX Socit Valuation analysis.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

## Complementary Tools for ABIVAX Pink Sheet analysis

When running ABIVAX Socit's price analysis, check to measure ABIVAX Socit's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABIVAX Socit is operating at the current time. Most of ABIVAX Socit's value examination focuses on studying past and present price action to predict the probability of ABIVAX Socit's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABIVAX Socit's price. Additionally, you may evaluate how the addition of ABIVAX Socit to your portfolios can decrease your overall portfolio volatility.
 Price Exposure ProbabilityAnalyze equity upside and downside potential for a given time horizon across multiple markets Performance AnalysisCheck effects of mean-variance optimization against your current asset allocation Portfolio RebalancingAnalyze risk-adjusted returns against different time horizons to find asset-allocation targets CEOs DirectoryScreen CEOs from public companies around the world Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years Correlation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated Portfolio File ImportQuickly import all of your third-party portfolios from your local drive in csv format Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories
Please note, there is a significant difference between ABIVAX Socit's value and its price as these two are different measures arrived at by different means. Investors typically determine if ABIVAX Socit is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ABIVAX Socit's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.